As is as important is all taxpayers of Australia as biotech R&D in these early stages is funded by the substantial R&D cash rebate that they get for qualified expenditures. Would hate to see CYP taken out by an overseas entity at this substantially discounted value IMO!
Ann: March 2025 Quarterly Activity Report and Appendix 4C, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.0¢ | 16.5¢ | $24.40K | 145.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 372794 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 42554 | 1 |
View Market Depth
| Last trade - 11.21am 16/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |